PubMed HealthSearch

Biomedical subjects

M E Ring

Publications and source records attributed to M E Ring.

At least 19 recordsLinked to original sources

Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985-1986 Percutaneous Transluminal Angioplasty Registry).

There has been increasing application of coronary angioplasty to patients with chronic total occlusions. The acute and long-term outcome in 271 patients after coronary angioplasty (142 single and 129 multiple stenoses) of a total occlusion was compared with 1,429 patients undergoing angioplasty of subtotal (less than or equal to 99% stenosis) occlusions (885 single and 544 multilesion) participating in the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Baseline characteristics were similar for each lesion group except for a higher incidence of prior myocardial infarction and left ventricular dysfunction (ejection fraction less than 50%) in patients with total occlusion. Major complications (death, myocardial infarction or emergency bypass surgery) were similar (p = not significant) between patients with total and subtotal occlusions for single (6 vs 7%) and multilesion angioplasty (9 vs 6%). At 2 years, after making adjustments for baseline variables, patients with a total occlusion had a significantly increased risk of death compared with those with subtotal occlusion. There were no significant differences in cumulative event rates for myocardial infarction or bypass surgery. Approximately three-fourths of patients in each group were free of angina at 2 years. In conclusion, angioplasty of chronic total occlusions is associated with a similar acute complication rate. Despite similar relief of anginal symptoms, patients in the total occlusion group have a higher 2-year mortality.

Aged

Detection of intracoronary fibrin degradation after coronary balloon angioplasty.

Intracoronary thrombus formation may be involved in the pathogenesis of arterial closure after coronary angioplasty and may contribute to restenosis. It is hypothesized that, unlike markers of platelet activation and fibrin formation, D-dimer, a product of plasmin-mediated proteolysis of cross-linked fibrin, is not subject to significant catheter-induced artifact and could be used to study intracoronary fibrin degradation during angioplasty. No significant difference in D-dimer levels was noted in serial plasma samples obtained from an 8Fr arterial sheath and the wire lumen of an angioplasty balloon catheter, indicating that sampling through the catheter lumen did not induce artifactual D-dimer elevations. Translesion (proximal and distal to the lesion) coronary blood samples were collected in 31 patients undergoing elective coronary angioplasty pretreated with aspirin, dipyridamole and heparin. In 20 of those in whom translesion coronary samples for plasma D-dimer levels (mean +/- standard deviation) were collected before balloon dilation, there was no evidence of ongoing intracoronary fibrinolysis (proximal D-dimer levels, 289 +/- 145 ng/ml; distal, 299 +/- 156 ng/ml; difference not significant). After coronary angioplasty (n = 31), there was a relatively small, but significant (p less than 0.001) increase (45 +/- 71 ng/ml) in translesional D-dimer levels (proximal, 396 +/- 223 ng/ml; distal, 441 +/- 257 ng/ml). The results from this study suggest (1) D-dimer levels are not subject to significant catheter-induced artifact and may be useful for assessment of intracoronary fibrin metabolism, and (2) intracoronary degradation of fibrin can be detected after (but not before) routine coronary angioplasty despite pretreatment with antithrombotic therapy, presumably in response to balloon-induced arterial injury and fibrin formation.

Aged

Comparison of catheter ablation using radiofrequency versus direct current energy: biophysical, electrophysiologic and pathologic observations.

The effects of catheter ablation with radiofrequency versus direct current energy were compared in 18 dogs assigned to two groups (of 9 dogs each). Each dog underwent a single ablation at two sites in the left ventricle at energy levels of 100, 200 or 300 J delivered in unipolar configuration to six dogs each. A transient decrease in left ventricular systolic pressure (from 121.3 +/- 24.5 to 94.2 +/- 18.7 mm Hg, p less than 0.01) and wall motion abnormality were noted in dogs with direct current shock. The left ventricular ejection fraction decreased (from 50 +/- 2% to 34 +/- 3%, p less than 0.001) shortly after direct current ablation but improved 4 weeks later to 43 +/- 3%. There were no significant changes in left ventricular pressure, wall motion or ejection fraction in dogs in the radiofrequency ablation group. Sustained ventricular tachycardia (greater than or equal to 30 s) was seen immediately after direct current shock in all dogs, and one dog died of intractable ventricular fibrillation. A 24-h ambulatory electrocardiographic (ECG) monitor obtained immediately after the procedure showed multiple runs of ventricular tachycardia in all dogs exposed to direct current ablation but in only three dogs that underwent radiofrequency ablation. No differences were found in peak creatine kinase, complete blood count with smear and B-beta 15-42 fibrinopeptide levels. Pathologically, direct current-induced lesions were larger (mean length x width x depth 10.9 x 7.5 x 5.2 vs. 4.8 x 4.6 x 4.3 mm) and were poorly circumscribed with inhomogeneous margins of necrosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals

History lesson.

Explore the source record for details and available documents.

Anesthesia, Dental

Attenuation of pulsus alternans during coronary angiography.

Following coronary angiography in a patient with cardiomyopathy and pulsus alternans, we observed a transient but marked attenuation of the alternation in pulse pressure associated with an elevation in pulmonary artery pressure. Attenuation of pulsus alternans has been rarely reported and may represent further deterioration of ventricular function.

Angiography

Catheter ablation of the ventricular septum with radiofrequency energy.

The safety and feasibility of performing catheter ablation of the ventricular septum with radiofrequency energy was assessed in a closed-chest canine model. Radiofrequency energy (750 kHz) was delivered in a bipolar manner via the distal electrodes of two quadripolar catheters positioned across the ventricular septum in 10 dogs at two sites. Each site received from 159 to 823 joules of delivered energy over one to three applications. Four additional dogs underwent unipolar radiofrequency ablation with 331 to 767 joules of delivered energy to each septal site. No significant acute or latent arrhythmias were noted. Dogs were killed at 1 day, and at 1, 2, and 4 weeks after the procedure. Out of a possible 40 potential ablation sites on each side of the septum after bipolar ablation, 21 (53%) discrete endocardial lesions were identified, ranging in size from 4 x 3 x 1.5 to 10 x 8 x 4 mm. When 352 joules or more delivered energy was applied per site, lesions were located at 18 of 28 (64%) possible sites. After unipolar radiofrequency ablation, similarly sized lesions were identified at 15 of 16 (94%) ablation sites. Histologic examination demonstrated well-delineated round or ovoid-shaped lesions with microscopic thrombi overlying two lesions. In conclusion, catheter ablation of the ventricular septum with radiofrequency energy appears capable of safely producing discrete areas of necrosis and may provide an alternative to direct current (DC) energy for catheter ablation of ventricular tachycardia originating from the septum.

Animals

Determinants of impedance rise during catheter ablation of bovine myocardium with radiofrequency energy.

Recently, radiofrequency (RF) energy has been used as an alternative energy source to direct-current (DC) electricity for catheter ablation of recurrent tachyarrhythmias. Since delivered energy is inversely related to impedance, factors that cause impedance rise during catheter ablation impede the ability to ablate tissue. To elucidate some of the factors responsible for impedance rise during RF (750 kHz) catheter ablation using a constant voltage RF generator, the effects of the following variables on impedance were studied in an in vitro bovine heart model: power setting (10-70 W), pulse duration (10-60 sec), catheter contact pressure (5-120 gm), repeated applications (2-4), and immersion media (saline vs citrated blood). Baseline impedance in blood was twice that of saline (190 vs 80 ohm) and rises in impedances occurred more rapidly in blood for the same energy settings. Increased power settings (greater than or equal to 30 W) and pulse duration (greater than or equal to 30 sec at 20 W) were associated with impedance rises in blood medium. Typically, impedance rises in blood were associated with blood coagulum on the catheter electrodes. Impedance rises in both saline and blood media were also associated with tissue charring and endocardial surface disruption. Once a rise in impedance occurred at the ablation site, repeated applications to the same site resulted in a more rapid rise in impedance. Catheter contact pressure of 80 gm or more also resulted in rapid impedance rise. These data suggest that factors other than set power and duration may also contribute to impedance rises during RF ablation. These findings may have important clinical implications in performing catheter ablation with RF energy.

Animals

Hemostatic markers in acute stroke.

To assess the time course of thrombosis and fibrinolysis after acute stroke, we measured concentrations of fibrinopeptide A (FpA), B-beta 1-42 peptide (B-beta 1-42), B-beta 15-42 peptide (B-beta 15-42), and crosslinked D-dimer (XDP) in 31 patients at varying times following acute ischemic stroke and in 13 neurologically stable patients with chronic strokes. FpA levels were markedly elevated during the first week after stroke and declined slowly during the first month. Mean FpA levels were not significantly elevated in chronic stroke patients. Mean XDP levels were slightly elevated during the first week and increased during the next 2 weeks after stroke. B-beta 1-42 and B-beta 15-42 levels were not elevated at any time following acute stroke. Our data suggest that fibrin formation greatly exceeds endogenous fibrinolysis during the acute phase of ischemic stroke. Endogenous fibrinolysis develops slowly following stroke. Prolonged elevation of FpA concentration suggests that thrombin activity and fibrin formation continue for up to 4 weeks in some patients with ischemic stroke.

Acute Disease